Hess Corp
F:AHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hess Corp
F:AHC
|
US |
|
V
|
Vicarious Surgical Inc
OTC:RBOT
|
US |
|
XSpray Pharma AB (publ)
F:6XP
|
SE |
|
W
|
Williams Companies Inc
DUS:WMB
|
US |
|
A
|
Agnico Eagle Mines Ltd
XMUN:AE9
|
CA |
|
Relmada Therapeutics Inc
F:4E2
|
US |
|
H
|
Helen of Troy Ltd
XMUN:HT2
|
BM |
|
A
|
Adocia SA
F:A89
|
FR |
|
Promotora y Operadora de Infraestructura SAB de CV
F:AKY
|
MX |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AHC's stock price target?
Not Available
AHC does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Hess Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been -4%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Hess Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Hess Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 11%.
